OPKO Health to Present at UBS 2008 Global Life Sciences Conference


OPKO Health, Inc. (AMEX:OPK) today announced that senior management will present at the UBS 2008 Global Life Sciences Conference on Tuesday, September 23, 2008 at 1:00 PM EDT. The conference will be held at the Grand Hyatt New York in New York City.

OPKO senior management will provide a review of recent corporate developments.

The audio portion of the company's presentation will be webcast live. To access the audio webcast go to the OPKO Health, Inc. website at www.opko.com and click on the icon for the presentation. An archived version of the webcast will be available for 30 days beginning three hours after the start of the presentation.

About OPKO Health, Inc.

Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the gene silencing agent bevasiranib, is in Phase III trials after successfully completing Phase II trials for wet age-related macular degeneration and diabetic macular edema. OPKO is developing a pipeline of novel agents for ophthalmic diseases, and it markets innovative diagnostic imaging systems that complement the company's therapeutic products. For more information visit the company's website at www.opko.com.

Source: OPKO Health, Inc.